<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2000-05-30" modified="2020-10-07" version="227">
<accession>O15392</accession>
<accession>A2SUH6</accession>
<accession>B2R4R1</accession>
<accession>Q2I3N8</accession>
<accession>Q4VGX0</accession>
<accession>Q53F61</accession>
<accession>Q5MGC6</accession>
<accession>Q6FHL2</accession>
<accession>Q75SP2</accession>
<accession>Q9P2W8</accession>
<name>BIRC5_HUMAN</name>
<protein>
<recommendedName>
<fullName>Baculoviral IAP repeat-containing protein 5</fullName>
</recommendedName>
<alternativeName>
<fullName>Apoptosis inhibitor 4</fullName>
</alternativeName>
<alternativeName>
<fullName>Apoptosis inhibitor survivin</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">BIRC5</name>
<name type="synonym">API4</name>
<name type="synonym">IAP4</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="Nat. Med." volume="3" first="917" last="921">
<title>A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma.</title>
<authorList>
<person name="Ambrosini G."/>
<person name="Adida C."/>
<person name="Altieri D.C."/>
</authorList>
<dbReference type="PubMed" id="9256286"/>
<dbReference type="DOI" id="10.1038/nm0897-917"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1999" name="Cancer Res." volume="59" first="6097" last="6102">
<title>Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties.</title>
<authorList>
<person name="Mahotka C."/>
<person name="Wenzel M."/>
<person name="Springer E."/>
<person name="Gabbert H.E."/>
<person name="Gerharz C.D."/>
</authorList>
<dbReference type="PubMed" id="10626797"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3)</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2000" name="Curr. Biol." volume="10" first="1319" last="1328">
<title>Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype.</title>
<authorList>
<person name="Uren A.G."/>
<person name="Wong L."/>
<person name="Pakusch M."/>
<person name="Fowler K.J."/>
<person name="Burrows F.J."/>
<person name="Vaux D.L."/>
<person name="Choo K.H."/>
</authorList>
<dbReference type="PubMed" id="11084331"/>
<dbReference type="DOI" id="10.1016/s0960-9822(00)00769-7"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Biochem. Biophys. Res. Commun." volume="314" first="902" last="907">
<title>Identification of a novel splice variant of the human anti-apoptosis gene survivin.</title>
<authorList>
<person name="Badran A."/>
<person name="Yoshida A."/>
<person name="Ishikawa K."/>
<person name="Goi T."/>
<person name="Yamaguchi A."/>
<person name="Ueda T."/>
<person name="Inuzuka M."/>
</authorList>
<dbReference type="PubMed" id="14741722"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2003.12.178"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4)</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Myeloid leukemia cell</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2005" name="DNA Seq." volume="16" first="321" last="328">
<title>Molecular cloning and bioinformatics analysis of a novel spliced variant of survivin from human breast cancer cells.</title>
<authorList>
<person name="Zheng W."/>
<person name="Ma X."/>
<person name="Wei D."/>
<person name="Wang T."/>
<person name="Ma Y."/>
<person name="Yang S."/>
</authorList>
<dbReference type="PubMed" id="16329164"/>
<dbReference type="DOI" id="10.1080/10425170500226490"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5)</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Mammary cancer</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="1999-06" db="EMBL/GenBank/DDBJ databases">
<title>An isoform of survivin (survivin-beta) which has 23 amino acids insertion into the BIR domain.</title>
<authorList>
<person name="Kageyama H."/>
<person name="Islam A."/>
<person name="Takayasu H."/>
<person name="Nakagawara A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Neuroblastoma</tissue>
</source>
</reference>
<reference key="7">
<citation type="submission" date="2005-02" db="EMBL/GenBank/DDBJ databases">
<title>Survivin 2 alpha: a novel survivin splice variant expressed in human malignancies.</title>
<authorList>
<person name="Caldas H."/>
<person name="Honsey L.E."/>
<person name="Altura R.A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 7)</scope>
</reference>
<reference key="8">
<citation type="submission" date="2005-11" db="EMBL/GenBank/DDBJ databases">
<title>Identification of a novel survivin splicing variant 3alpha in acute myeloid leukemia.</title>
<authorList>
<person name="Vietri M.T."/>
<person name="Cioffi M."/>
<person name="Sessa M."/>
<person name="Sica V."/>
<person name="Molinari A.M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6)</scope>
<source>
<tissue>Myeloid leukemia cell</tissue>
</source>
</reference>
<reference key="9">
<citation type="submission" date="2004-06" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201).</title>
<authorList>
<person name="Ebert L."/>
<person name="Schick M."/>
<person name="Neubert P."/>
<person name="Schatten R."/>
<person name="Henze S."/>
<person name="Korn B."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="11">
<citation type="submission" date="2005-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="12">
<citation type="submission" date="2004-10" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="Nature" volume="440" first="1045" last="1049">
<title>DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.</title>
<authorList>
<person name="Zody M.C."/>
<person name="Garber M."/>
<person name="Adams D.J."/>
<person name="Sharpe T."/>
<person name="Harrow J."/>
<person name="Lupski J.R."/>
<person name="Nicholson C."/>
<person name="Searle S.M."/>
<person name="Wilming L."/>
<person name="Young S.K."/>
<person name="Abouelleil A."/>
<person name="Allen N.R."/>
<person name="Bi W."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Bugalter B.E."/>
<person name="Butler J."/>
<person name="Chang J.L."/>
<person name="Chen C.-K."/>
<person name="Cook A."/>
<person name="Corum B."/>
<person name="Cuomo C.A."/>
<person name="de Jong P.J."/>
<person name="DeCaprio D."/>
<person name="Dewar K."/>
<person name="FitzGerald M."/>
<person name="Gilbert J."/>
<person name="Gibson R."/>
<person name="Gnerre S."/>
<person name="Goldstein S."/>
<person name="Grafham D.V."/>
<person name="Grocock R."/>
<person name="Hafez N."/>
<person name="Hagopian D.S."/>
<person name="Hart E."/>
<person name="Norman C.H."/>
<person name="Humphray S."/>
<person name="Jaffe D.B."/>
<person name="Jones M."/>
<person name="Kamal M."/>
<person name="Khodiyar V.K."/>
<person name="LaButti K."/>
<person name="Laird G."/>
<person name="Lehoczky J."/>
<person name="Liu X."/>
<person name="Lokyitsang T."/>
<person name="Loveland J."/>
<person name="Lui A."/>
<person name="Macdonald P."/>
<person name="Major J.E."/>
<person name="Matthews L."/>
<person name="Mauceli E."/>
<person name="McCarroll S.A."/>
<person name="Mihalev A.H."/>
<person name="Mudge J."/>
<person name="Nguyen C."/>
<person name="Nicol R."/>
<person name="O'Leary S.B."/>
<person name="Osoegawa K."/>
<person name="Schwartz D.C."/>
<person name="Shaw-Smith C."/>
<person name="Stankiewicz P."/>
<person name="Steward C."/>
<person name="Swarbreck D."/>
<person name="Venkataraman V."/>
<person name="Whittaker C.A."/>
<person name="Yang X."/>
<person name="Zimmer A.R."/>
<person name="Bradley A."/>
<person name="Hubbard T."/>
<person name="Birren B.W."/>
<person name="Rogers J."/>
<person name="Lander E.S."/>
<person name="Nusbaum C."/>
</authorList>
<dbReference type="PubMed" id="16625196"/>
<dbReference type="DOI" id="10.1038/nature04689"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANT GLU-129</scope>
</reference>
<reference key="14">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Lung</tissue>
<tissue>Mammary gland</tissue>
<tissue>Muscle</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="1998" name="Nature" volume="396" first="580" last="584">
<title>Control of apoptosis and mitotic spindle checkpoint by survivin.</title>
<authorList>
<person name="Li F."/>
<person name="Ambrosini G."/>
<person name="Chu E.Y."/>
<person name="Plescia J."/>
<person name="Tognin S."/>
<person name="Marchisio P.C."/>
<person name="Altieri D.C."/>
</authorList>
<dbReference type="PubMed" id="9859993"/>
<dbReference type="DOI" id="10.1038/25141"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="13103" last="13107">
<title>Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin.</title>
<authorList>
<person name="O'Connor D.S."/>
<person name="Grossman D."/>
<person name="Plescia J."/>
<person name="Li F."/>
<person name="Zhang H."/>
<person name="Villa A."/>
<person name="Tognin S."/>
<person name="Marchisio P.C."/>
<person name="Altieri D.C."/>
</authorList>
<dbReference type="PubMed" id="11069302"/>
<dbReference type="DOI" id="10.1073/pnas.240390697"/>
</citation>
<scope>PHOSPHORYLATION AT THR-34</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2003" name="EMBO J." volume="22" first="2729" last="2740">
<title>HBXIP functions as a cofactor of survivin in apoptosis suppression.</title>
<authorList>
<person name="Marusawa H."/>
<person name="Matsuzawa S."/>
<person name="Welsh K."/>
<person name="Zou H."/>
<person name="Armstrong R."/>
<person name="Tamm I."/>
<person name="Reed J.C."/>
</authorList>
<dbReference type="PubMed" id="12773388"/>
<dbReference type="DOI" id="10.1093/emboj/cdg263"/>
</citation>
<scope>FUNCTION IN APOPTOSIS SUPPRESSION</scope>
<scope>INTERACTION WITH LAMTOR5/HBXIP</scope>
<scope>MUTAGENESIS OF THR-34</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="5655" last="5660">
<title>Aurora-B phosphorylation in vitro identifies a residue of survivin that is essential for its localization and binding to inner centromere protein (INCENP) in vivo.</title>
<authorList>
<person name="Wheatley S.P."/>
<person name="Henzing A.J."/>
<person name="Dodson H."/>
<person name="Khaled W."/>
<person name="Earnshaw W.C."/>
</authorList>
<dbReference type="PubMed" id="14610074"/>
<dbReference type="DOI" id="10.1074/jbc.m311299200"/>
</citation>
<scope>INTERACTION WITH INCENP</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT THR-117</scope>
<scope>MUTAGENESIS OF THR-117</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2004" name="J. Cell Biol." volume="166" first="179" last="191">
<title>Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle.</title>
<authorList>
<person name="Gassmann R."/>
<person name="Carvalho A."/>
<person name="Henzing A.J."/>
<person name="Ruchaud S."/>
<person name="Hudson D.F."/>
<person name="Honda R."/>
<person name="Nigg E.A."/>
<person name="Gerloff D.L."/>
<person name="Earnshaw W.C."/>
</authorList>
<dbReference type="PubMed" id="15249581"/>
<dbReference type="DOI" id="10.1083/jcb.200404001"/>
</citation>
<scope>INTERACTION WITH CDCA8</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2005" name="Cancer Res." volume="65" first="210" last="218">
<title>cIAP1 Localizes to the nuclear compartment and modulates the cell cycle.</title>
<authorList>
<person name="Samuel T."/>
<person name="Okada K."/>
<person name="Hyer M."/>
<person name="Welsh K."/>
<person name="Zapata J.M."/>
<person name="Reed J.C."/>
</authorList>
<dbReference type="PubMed" id="15665297"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH BIRC2/C-IAP1</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2005" name="Int. Rev. Cytol." volume="247" first="35" last="88">
<title>Survivin: a protein with dual roles in mitosis and apoptosis.</title>
<authorList>
<person name="Wheatley S.P."/>
<person name="McNeish I.A."/>
</authorList>
<dbReference type="PubMed" id="16344111"/>
<dbReference type="DOI" id="10.1016/s0074-7696(05)47002-3"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2005" name="Science" volume="310" first="1499" last="1504">
<title>Chromosome alignment and segregation regulated by ubiquitination of survivin.</title>
<authorList>
<person name="Vong Q.P."/>
<person name="Cao K."/>
<person name="Li H.Y."/>
<person name="Iglesias P.A."/>
<person name="Zheng Y."/>
</authorList>
<dbReference type="PubMed" id="16322459"/>
<dbReference type="DOI" id="10.1126/science.1120160"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH USP9X</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF LYS-23; LYS-62; LYS-78 AND LYS-79</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2006" name="Biochem. Biophys. Res. Commun." volume="346" first="400" last="407">
<title>Survivin mutant (Surv-DD70, 71AA) disrupts the interaction of Survivin with Aurora B and causes multinucleation in HeLa cells.</title>
<authorList>
<person name="Cao L."/>
<person name="Yan X."/>
<person name="Wu Y."/>
<person name="Hu H."/>
<person name="Li Q."/>
<person name="Zhou T."/>
<person name="Jiang S."/>
<person name="Yu L."/>
</authorList>
<dbReference type="PubMed" id="16762323"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2006.05.131"/>
</citation>
<scope>MUTAGENESIS OF ASP-70; ASP-71 AND 70-ASP--ASP-71</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2006" name="EMBO Rep." volume="7" first="85" last="92">
<title>Survivin mediates targeting of the chromosomal passenger complex to the centromere and midbody.</title>
<authorList>
<person name="Vader G."/>
<person name="Kauw J.J.W."/>
<person name="Medema R.H."/>
<person name="Lens S.M.A."/>
</authorList>
<dbReference type="PubMed" id="16239925"/>
<dbReference type="DOI" id="10.1038/sj.embor.7400562"/>
</citation>
<scope>INTERACTION WITH CDCA8</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2006" name="Exp. Cell Res." volume="312" first="962" last="973">
<title>Borealin/Dasra B is a cell cycle-regulated chromosomal passenger protein and its nuclear accumulation is linked to poor prognosis for human gastric cancer.</title>
<authorList>
<person name="Chang J.-L."/>
<person name="Chen T.-H."/>
<person name="Wang C.-F."/>
<person name="Chiang Y.-H."/>
<person name="Huang Y.-L."/>
<person name="Wong F.-H."/>
<person name="Chou C.-K."/>
<person name="Chen C.-M."/>
</authorList>
<dbReference type="PubMed" id="16427043"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2005.12.015"/>
</citation>
<scope>INTERACTION WITH CDCA8</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2006" name="Exp. Cell Res." volume="312" first="2325" last="2335">
<title>EVI5 protein associates with the INCENP-aurora B kinase-survivin chromosomal passenger complex and is involved in the completion of cytokinesis.</title>
<authorList>
<person name="Faitar S.L."/>
<person name="Sossey-Alaoui K."/>
<person name="Ranalli T.A."/>
<person name="Cowell J.K."/>
</authorList>
<dbReference type="PubMed" id="16764853"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2006.03.032"/>
</citation>
<scope>INTERACTION WITH EVI5</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="1286" last="1295">
<title>Molecular analysis of survivin isoforms: evidence that alternatively spliced variants do not play a role in mitosis.</title>
<authorList>
<person name="Noton E.A."/>
<person name="Colnaghi R."/>
<person name="Tate S."/>
<person name="Starck C."/>
<person name="Carvalho A."/>
<person name="Ko Ferrigno P."/>
<person name="Wheatley S.P."/>
</authorList>
<dbReference type="PubMed" id="16291752"/>
<dbReference type="DOI" id="10.1074/jbc.m508773200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CDCA8</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2006" name="Mol. Biol. Cell" volume="17" first="1897" last="1909">
<title>Uncoupling the central spindle-associated function of the chromosomal passenger complex from its role at centromeres.</title>
<authorList>
<person name="Lens S.M.A."/>
<person name="Rodriguez J.A."/>
<person name="Vader G."/>
<person name="Span S.W."/>
<person name="Giaccone G."/>
<person name="Medema R.H."/>
</authorList>
<dbReference type="PubMed" id="16436504"/>
<dbReference type="DOI" id="10.1091/mbc.e05-08-0727"/>
</citation>
<scope>INTERACTION WITH CDCA8</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2008" name="Cell" volume="132" first="832" last="845">
<title>Final stages of cytokinesis and midbody ring formation are controlled by BRUCE.</title>
<authorList>
<person name="Pohl C."/>
<person name="Jentsch S."/>
</authorList>
<dbReference type="PubMed" id="18329369"/>
<dbReference type="DOI" id="10.1016/j.cell.2008.01.012"/>
</citation>
<scope>INTERACTION WITH BIRC6/BRUCE</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="648" last="659">
<title>Cartilage oligomeric matrix protein protects cells against death by elevating members of the IAP family of survival proteins.</title>
<authorList>
<person name="Gagarina V."/>
<person name="Carlberg A.L."/>
<person name="Pereira-Mouries L."/>
<person name="Hall D.J."/>
</authorList>
<dbReference type="PubMed" id="17993464"/>
<dbReference type="DOI" id="10.1074/jbc.m704035200"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-34</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2008" name="Mol. Cell. Biol." volume="28" first="5299" last="5311">
<title>A survivin-ran complex regulates spindle formation in tumor cells.</title>
<authorList>
<person name="Xia F."/>
<person name="Canovas P.M."/>
<person name="Guadagno T.M."/>
<person name="Altieri D.C."/>
</authorList>
<dbReference type="PubMed" id="18591255"/>
<dbReference type="DOI" id="10.1128/mcb.02039-07"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RAN; AURKB AND CDCA8</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DEVELOPMENTAL STAGE</scope>
<scope>MUTAGENESIS OF GLU-65</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2010" name="Cell Death Dis." volume="1" first="E51" last="E51">
<title>An otoprotective role for the apoptosis inhibitor protein survivin.</title>
<authorList>
<person name="Knauer S.K."/>
<person name="Heinrich U.R."/>
<person name="Bier C."/>
<person name="Habtemichael N."/>
<person name="Docter D."/>
<person name="Helling K."/>
<person name="Mann W.J."/>
<person name="Stauber R.H."/>
</authorList>
<dbReference type="PubMed" id="21364656"/>
<dbReference type="DOI" id="10.1038/cddis.2010.25"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="36129" last="36137">
<title>Acetylation directs survivin nuclear localization to repress STAT3 oncogenic activity.</title>
<authorList>
<person name="Wang H."/>
<person name="Holloway M.P."/>
<person name="Ma L."/>
<person name="Cooper Z.A."/>
<person name="Riolo M."/>
<person name="Samkari A."/>
<person name="Elenitoba-Johnson K.S."/>
<person name="Chin Y.E."/>
<person name="Altura R.A."/>
</authorList>
<dbReference type="PubMed" id="20826784"/>
<dbReference type="DOI" id="10.1074/jbc.m110.152777"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH STAT3 AND XPO1/CRM1</scope>
<scope>ACETYLATION AT LYS-23; LYS-90; LYS-110; LYS-112; LYS-115; LYS-121 AND LYS-129</scope>
<scope>MUTAGENESIS OF LYS-129</scope>
<scope>CHARACTERIZATION OF VARIANT GLU-129</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2010" name="Mol. Cell. Neurosci." volume="45" first="297" last="305">
<title>Expression analysis suggests a potential cytoprotective role of Birc5 in the inner ear.</title>
<authorList>
<person name="Habtemichael N."/>
<person name="Heinrich U.R."/>
<person name="Knauer S.K."/>
<person name="Schmidtmann I."/>
<person name="Bier C."/>
<person name="Docter D."/>
<person name="Brochhausen C."/>
<person name="Helling K."/>
<person name="Brieger J."/>
<person name="Stauber R.H."/>
<person name="Mann W.J."/>
</authorList>
<dbReference type="PubMed" id="20627126"/>
<dbReference type="DOI" id="10.1016/j.mcn.2010.07.003"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2010" name="Science" volume="330" first="239" last="243">
<title>Two histone marks establish the inner centromere and chromosome bi-orientation.</title>
<authorList>
<person name="Yamagishi Y."/>
<person name="Honda T."/>
<person name="Tanno Y."/>
<person name="Watanabe Y."/>
</authorList>
<dbReference type="PubMed" id="20929775"/>
<dbReference type="DOI" id="10.1126/science.1194498"/>
</citation>
<scope>FUNCTION</scope>
<scope>HISTONE-BINDING</scope>
<scope>MUTAGENESIS OF ARG-18; TRP-25; CYS-33; CYS-57 AND TRP-67</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2011" name="Cell Cycle" volume="10" first="538" last="548">
<title>Threonine 48 in the BIR domain of survivin is critical to its mitotic and anti-apoptotic activities and can be phosphorylated by CK2 in vitro.</title>
<authorList>
<person name="Barrett R.M."/>
<person name="Colnaghi R."/>
<person name="Wheatley S.P."/>
</authorList>
<dbReference type="PubMed" id="21252625"/>
<dbReference type="DOI" id="10.4161/cc.10.3.14758"/>
</citation>
<scope>PHOSPHORYLATION AT THR-48</scope>
<scope>MUTAGENESIS OF THR-48</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2011" name="Int. J. Oncol." volume="38" first="777" last="785">
<title>PAR, a protein involved in the cell cycle, is functionally related to chromosomal passenger proteins.</title>
<authorList>
<person name="Platica M."/>
<person name="Ionescu A."/>
<person name="Ivan E."/>
<person name="Holland J.F."/>
<person name="Mandeli J."/>
<person name="Platica O."/>
</authorList>
<dbReference type="PubMed" id="21225229"/>
<dbReference type="DOI" id="10.3892/ijo.2011.900"/>
</citation>
<scope>INTERACTION WITH JTB</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="23296" last="23307">
<title>Survivin monomer plays an essential role in apoptosis regulation.</title>
<authorList>
<person name="Pavlyukov M.S."/>
<person name="Antipova N.V."/>
<person name="Balashova M.V."/>
<person name="Vinogradova T.V."/>
<person name="Kopantzev E.P."/>
<person name="Shakhparonov M.I."/>
</authorList>
<dbReference type="PubMed" id="21536684"/>
<dbReference type="DOI" id="10.1074/jbc.m111.237586"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH XIAP/BIRC4 AND DIABLO/SMAC</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2014" name="Biochem. Biophys. Res. Commun." volume="450" first="129" last="134">
<title>ALS2CR7 (CDK15) attenuates TRAIL induced apoptosis by inducing phosphorylation of survivin Thr34.</title>
<authorList>
<person name="Park M.H."/>
<person name="Kim S.Y."/>
<person name="Kim Y.J."/>
<person name="Chung Y.H."/>
</authorList>
<dbReference type="PubMed" id="24866247"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2014.05.070"/>
</citation>
<scope>PHOSPHORYLATION AT THR-34 BY CDK15</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2014" name="Mol. Cell" volume="54" first="805" last="819">
<title>CUL9 mediates the functions of the 3M complex and ubiquitylates survivin to maintain genome integrity.</title>
<authorList>
<person name="Li Z."/>
<person name="Pei X.H."/>
<person name="Yan J."/>
<person name="Yan F."/>
<person name="Cappell K.M."/>
<person name="Whitehurst A.W."/>
<person name="Xiong Y."/>
</authorList>
<dbReference type="PubMed" id="24793696"/>
<dbReference type="DOI" id="10.1016/j.molcel.2014.03.046"/>
</citation>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2015" name="J. Biol. Chem." volume="290" first="11843" last="11852">
<title>The Proapoptotic F-box Protein Fbxl7 Regulates Mitochondrial Function by Mediating the Ubiquitylation and Proteasomal Degradation of Survivin.</title>
<authorList>
<person name="Liu Y."/>
<person name="Lear T."/>
<person name="Iannone O."/>
<person name="Shiva S."/>
<person name="Corey C."/>
<person name="Rajbhandari S."/>
<person name="Jerome J."/>
<person name="Chen B.B."/>
<person name="Mallampalli R.K."/>
</authorList>
<dbReference type="PubMed" id="25778398"/>
<dbReference type="DOI" id="10.1074/jbc.m114.629931"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH FBXL7</scope>
<scope>MUTAGENESIS OF 90-LYS-LYS-91 AND GLU-126</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2016" name="PLoS ONE" volume="11" first="E0157305" last="E0157305">
<title>Aurora-C interactions with survivin and INCENP reveal shared and distinct features compared with Aurora-B chromosome passenger protein complex.</title>
<authorList>
<person name="Sasai K."/>
<person name="Katayama H."/>
<person name="Hawke D.H."/>
<person name="Sen S."/>
</authorList>
<dbReference type="PubMed" id="27332895"/>
<dbReference type="DOI" id="10.1371/journal.pone.0157305"/>
</citation>
<scope>SUBUNIT</scope>
<scope>PHOSPHORYLATION AT SER-20</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2017" name="Oncogenesis" volume="6" first="E298" last="E298">
<title>Aurora kinase A regulates Survivin stability through targeting FBXL7 in gastric cancer drug resistance and prognosis.</title>
<authorList>
<person name="Kamran M."/>
<person name="Long Z.J."/>
<person name="Xu D."/>
<person name="Lv S.S."/>
<person name="Liu B."/>
<person name="Wang C.L."/>
<person name="Xu J."/>
<person name="Lam E.W."/>
<person name="Liu Q."/>
</authorList>
<dbReference type="PubMed" id="28218735"/>
<dbReference type="DOI" id="10.1038/oncsis.2016.80"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH FBXL7</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2000" name="Mol. Cell" volume="6" first="183" last="189">
<title>Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual alpha-helical extensions.</title>
<authorList>
<person name="Chantalat L."/>
<person name="Skoufias D.A."/>
<person name="Kleman J.P."/>
<person name="Jung B."/>
<person name="Dideberg O."/>
<person name="Margolis R.L."/>
</authorList>
<dbReference type="PubMed" id="10949039"/>
<dbReference type="DOI" id="10.1016/s1097-2765(05)00020-1"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.71 ANGSTROMS) OF ISOFORM 1</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2000" name="Nat. Struct. Biol." volume="7" first="602" last="608">
<title>Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement.</title>
<authorList>
<person name="Verdecia M.A."/>
<person name="Huang H."/>
<person name="Dutil E."/>
<person name="Kaiser D.A."/>
<person name="Hunter T."/>
<person name="Noel J.P."/>
</authorList>
<dbReference type="PubMed" id="10876248"/>
<dbReference type="DOI" id="10.1038/76838"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.58 ANGSTROMS) OF ISOFORM 1</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2007" name="Cell" volume="131" first="271" last="285">
<title>Structure of a Survivin-Borealin-INCENP core complex reveals how chromosomal passengers travel together.</title>
<authorList>
<person name="Jeyaprakash A.A."/>
<person name="Klein U.R."/>
<person name="Lindner D."/>
<person name="Ebert J."/>
<person name="Nigg E.A."/>
<person name="Conti E."/>
</authorList>
<dbReference type="PubMed" id="17956729"/>
<dbReference type="DOI" id="10.1016/j.cell.2007.07.045"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) IN COMPLEX WITH ZINC IONS</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH CDCA8 AND INCENP</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2009" name="Biochemistry" volume="48" first="6783" last="6793">
<title>Phosphorylation of a borealin dimerization domain is required for proper chromosome segregation.</title>
<authorList>
<person name="Bourhis E."/>
<person name="Lingel A."/>
<person name="Phung Q."/>
<person name="Fairbrother W.J."/>
<person name="Cochran A.G."/>
</authorList>
<dbReference type="PubMed" id="19530738"/>
<dbReference type="DOI" id="10.1021/bi900530v"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS)</scope>
</reference>
<comment type="function">
<text evidence="7 10 16 17 27 28 29 30 33 34 37 39 40">Multitasking protein that has dual roles in promoting cell proliferation and preventing apoptosis (PubMed:9859993, PubMed:21364656, PubMed:20627126, PubMed:25778398, PubMed:28218735). Component of a chromosome passage protein complex (CPC) which is essential for chromosome alignment and segregation during mitosis and cytokinesis (PubMed:16322459). Acts as an important regulator of the localization of this complex; directs CPC movement to different locations from the inner centromere during prometaphase to midbody during cytokinesis and participates in the organization of the center spindle by associating with polymerized microtubules (PubMed:20826784). Involved in the recruitment of CPC to centromeres during early mitosis via association with histone H3 phosphorylated at 'Thr-3' (H3pT3) during mitosis (PubMed:20929775). The complex with RAN plays a role in mitotic spindle formation by serving as a physical scaffold to help deliver the RAN effector molecule TPX2 to microtubules (PubMed:18591255). May counteract a default induction of apoptosis in G2/M phase (PubMed:9859993). The acetylated form represses STAT3 transactivation of target gene promoters (PubMed:20826784). May play a role in neoplasia (PubMed:10626797). Inhibitor of CASP3 and CASP7 (PubMed:21536684). Essential for the maintenance of mitochondrial integrity and function (PubMed:25778398). Isoform 2 and isoform 3 do not appear to play vital roles in mitosis (PubMed:12773388, PubMed:16291752). Isoform 3 shows a marked reduction in its anti-apoptotic effects when compared with the displayed wild-type isoform (PubMed:10626797).</text>
</comment>
<comment type="subunit">
<text evidence="10 11 13 14 15 16 17 19 20 23 24 26 27 29 31 34 37 39">Monomer or homodimer. Exists as a homodimer in the apo state and as a monomer in the CPC-bound state. The monomer protects cells against apoptosis more efficiently than the dimer. Only the dimeric form is capable of enhancing tubulin stability in cells. When phosphorylated, interacts with LAMTOR5/HBXIP; the resulting complex binds pro-CASP9, as well as active CASP9, but much less efficiently. Component of the chromosomal passenger complex (CPC) composed of at least BIRC5/survivin, CDCA8/borealin, INCENP, AURKB or AURKC; in the complex forms a triple-helix bundle-based subcomplex with INCENP and CDCA8 (PubMed:17956729). Interacts with JTB. Interacts (via BIR domain) with histone H3 phosphorylated at 'Thr-3' (H3pT3). Interacts with EVI5. Interacts with GTP-bound RAN in both the S and M phases of the cell cycle. Interacts with USP9X. Interacts with tubulin. Interacts with BIRC2/c-IAP1. The acetylated form at Lys-129 interacts with STAT3. The monomeric form deacetylated at Lys-129 interacts with XPO1/CRM1. The monomeric form interacts with XIAP/BIRC4. Both the dimeric and monomeric form can interact with DIABLO/SMAC. Interacts with BIRC6/bruce. Interacts with FBXL7; this interaction facilitates the polyubiquitination and subsequent proteasomal degradation of BIRC5 by the SCF(FBXL7) E3 ubiquitin-protein ligase complex (PubMed:25778398, PubMed:28218735).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518823">
<id>O15392</id>
</interactant>
<interactant intactId="EBI-448680">
<id>O14965</id>
<label>AURKA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518823">
<id>O15392</id>
</interactant>
<interactant intactId="EBI-624291">
<id>Q96GD4</id>
<label>AURKB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518823">
<id>O15392</id>
</interactant>
<interactant intactId="EBI-3926851">
<id>Q9UQB9</id>
<label>AURKC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518823">
<id>O15392</id>
</interactant>
<interactant intactId="EBI-949378">
<id>Q14457</id>
<label>BECN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518823">
<id>O15392</id>
</interactant>
<interactant intactId="EBI-518823">
<id>O15392</id>
<label>BIRC5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518823">
<id>O15392</id>
</interactant>
<interactant intactId="EBI-516799">
<id>P55211</id>
<label>CASP9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518823">
<id>O15392</id>
</interactant>
<interactant intactId="EBI-739674">
<id>Q15834</id>
<label>CCDC85B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518823">
<id>O15392</id>
</interactant>
<interactant intactId="EBI-979174">
<id>Q53HL2</id>
<label>CDCA8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>19</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518823">
<id>O15392</id>
</interactant>
<interactant intactId="EBI-444308">
<id>P06493</id>
<label>CDK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518823">
<id>O15392</id>
</interactant>
<interactant intactId="EBI-517508">
<id>Q9NR28</id>
<label>DIABLO</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518823">
<id>O15392</id>
</interactant>
<interactant intactId="EBI-9248152">
<id>Q86XJ1</id>
<label>GAS2L3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518823">
<id>O15392</id>
</interactant>
<interactant intactId="EBI-307907">
<id>Q9NQS7</id>
<label>INCENP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518823">
<id>O15392</id>
</interactant>
<interactant intactId="EBI-10173304">
<id>A0A0C4DGV4</id>
<label>LAMTOR5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518823">
<id>O15392</id>
</interactant>
<interactant intactId="EBI-286642">
<id>P62826</id>
<label>RAN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518823">
<id>O15392</id>
</interactant>
<interactant intactId="EBI-355867">
<id>O14980</id>
<label>XPO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518838">
<id>O15392-1</id>
</interactant>
<interactant intactId="EBI-624291">
<id>Q96GD4</id>
<label>AURKB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518838">
<id>O15392-1</id>
</interactant>
<interactant intactId="EBI-518838">
<id>O15392-1</id>
<label>BIRC5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518838">
<id>O15392-1</id>
</interactant>
<interactant intactId="EBI-979174">
<id>Q53HL2</id>
<label>CDCA8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518842">
<id>O15392-2</id>
</interactant>
<interactant intactId="EBI-624291">
<id>Q96GD4</id>
<label>AURKB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518842">
<id>O15392-2</id>
</interactant>
<interactant intactId="EBI-518838">
<id>O15392-1</id>
<label>BIRC5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518842">
<id>O15392-2</id>
</interactant>
<interactant intactId="EBI-979174">
<id>Q53HL2</id>
<label>CDCA8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="28 29 33">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="28 29 33">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="11">Chromosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9 11 17">Chromosome</location>
<location evidence="9 11 17">Centromere</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Cytoplasm</location>
<location evidence="9">Cytoskeleton</location>
<location evidence="9">Spindle</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Chromosome</location>
<location evidence="9">Centromere</location>
<location evidence="9">Kinetochore</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="14">Midbody</location>
</subcellularLocation>
<text evidence="6 9 11 29">Localizes at the centromeres from prophase to metaphase, at the spindle midzone during anaphase and a the midbody during telophase and cytokinesis. Accumulates in the nucleus upon treatment with leptomycin B (LMB), a XPO1/CRM1 nuclear export inhibitor (By similarity). Localizes on chromosome arms and inner centromeres from prophase through metaphase. Localizes to kinetochores in metaphase, distributes to the midzone microtubules in anaphase and at telophase, localizes exclusively to the midbody (PubMed:11084331). Colocalizes with AURKB at mitotic chromosomes (PubMed:14610074). Acetylation at Lys-129 directs its localization to the nucleus by enhancing homodimerization and thereby inhibiting XPO1/CRM1-mediated nuclear export (PubMed:20826784).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O15392-1</id>
<name>1</name>
<name>Alpha</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O15392-2</id>
<name>2</name>
<name>2B</name>
<name>Beta</name>
<sequence type="described" ref="VSP_002454"/>
</isoform>
<isoform>
<id>O15392-3</id>
<name>3</name>
<name>DeltaEx3</name>
<sequence type="described" ref="VSP_020338"/>
</isoform>
<isoform>
<id>O15392-4</id>
<name>4</name>
<name>3B</name>
<sequence type="described" ref="VSP_020342"/>
</isoform>
<isoform>
<id>O15392-5</id>
<name>5</name>
<name>SI</name>
<sequence type="described" ref="VSP_020341"/>
</isoform>
<isoform>
<id>O15392-6</id>
<name>6</name>
<name>3 alpha</name>
<sequence type="described" ref="VSP_020339"/>
</isoform>
<isoform>
<id>O15392-7</id>
<name>7</name>
<name>2 alpha</name>
<sequence type="described" ref="VSP_020340"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="7 12 18 28 33">Expressed only in fetal kidney and liver, and to lesser extent, lung and brain (PubMed:10626797). Abundantly expressed in adenocarcinoma (lung, pancreas, colon, breast, and prostate) and in high-grade lymphomas (PubMed:14741722, PubMed:16329164). Also expressed in various renal cell carcinoma cell lines (PubMed:10626797). Expressed in cochlea including the organ of Corti, the lateral wall, the interdental cells of the Limbus as well as in Schwann cells and cells of the cochlear nerve and the spiral ganglions (at protein level). Not expressed in cells of the inner and outer sulcus or the Reissner's membrane (at protein level) (PubMed:21364656, PubMed:20627126).</text>
</comment>
<comment type="developmental stage">
<text evidence="27">Expression is cell cycle-dependent and peaks at mitosis.</text>
</comment>
<comment type="induction">
<text evidence="25">Up-regulated by COMP.</text>
</comment>
<comment type="domain">
<text evidence="10">The BIR repeat is necessary and sufficient for LAMTOR5 binding.</text>
</comment>
<comment type="PTM">
<text evidence="17 35">Ubiquitinated by the Cul9-RING ubiquitin-protein ligase complex, leading to its degradation. Ubiquitination is required for centrosomal targeting.</text>
</comment>
<comment type="PTM">
<text evidence="8 11 32 36 38">In vitro phosphorylation at Thr-117 by AURKB prevents interaction with INCENP and localization to mitotic chromosomes (PubMed:14610074). Phosphorylation at Thr-48 by CK2 is critical for its mitotic and anti-apoptotic activities (PubMed:21252625). Phosphorylation at Thr-34 by CDK15 is critical for its anti-apoptotic activity (PubMed:24866247). Phosphorylation at Ser-20 by AURKC is critical for regulation of proper chromosome alignment and segregation, and possibly cytokinesis.</text>
</comment>
<comment type="PTM">
<text evidence="29">Acetylation at Lys-129 by CBP results in its homodimerization, while deacetylation promotes the formation of monomers which heterodimerize with XPO1/CRM1 which facilitates its nuclear export. The acetylated form represses STAT3 transactivation. The dynamic equilibrium between its acetylation and deacetylation at Lys-129 determines its interaction with XPO1/CRM1, its subsequent subcellular localization, and its ability to inhibit STAT3 transactivation.</text>
</comment>
<comment type="similarity">
<text evidence="47">Belongs to the IAP family.</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/birc5/"/>
</comment>
<dbReference type="EMBL" id="U75285">
<property type="protein sequence ID" value="AAC51660.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF077350">
<property type="protein sequence ID" value="AAD34226.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB154416">
<property type="protein sequence ID" value="BAD11155.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY830084">
<property type="protein sequence ID" value="AAW22624.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB028869">
<property type="protein sequence ID" value="BAA93676.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY927772">
<property type="protein sequence ID" value="AAY15202.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ227257">
<property type="protein sequence ID" value="ABB76601.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ310375">
<property type="protein sequence ID" value="ABC42341.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ310376">
<property type="protein sequence ID" value="ABC42342.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ310377">
<property type="protein sequence ID" value="ABC42343.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ310378">
<property type="protein sequence ID" value="ABC42344.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ310379">
<property type="protein sequence ID" value="ABC42345.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR541740">
<property type="protein sequence ID" value="CAG46540.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK223428">
<property type="protein sequence ID" value="BAD97148.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK311917">
<property type="protein sequence ID" value="BAG34858.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY795969">
<property type="protein sequence ID" value="AAV40840.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC087645">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471099">
<property type="protein sequence ID" value="EAW89514.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC008718">
<property type="protein sequence ID" value="AAH08718.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC034148">
<property type="protein sequence ID" value="AAH34148.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC065497">
<property type="protein sequence ID" value="AAH65497.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11755.1">
<molecule id="O15392-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS32751.1">
<molecule id="O15392-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS32752.1">
<molecule id="O15392-2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001012270.1">
<molecule id="O15392-3"/>
<property type="nucleotide sequence ID" value="NM_001012270.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001012271.1">
<property type="nucleotide sequence ID" value="NM_001012271.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001159.2">
<property type="nucleotide sequence ID" value="NM_001168.2"/>
</dbReference>
<dbReference type="PDB" id="1E31">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.71"/>
<property type="chains" value="A/B=1-142"/>
</dbReference>
<dbReference type="PDB" id="1F3H">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.58"/>
<property type="chains" value="A/B=1-142"/>
</dbReference>
<dbReference type="PDB" id="1XOX">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=1-117"/>
</dbReference>
<dbReference type="PDB" id="2QFA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A=1-142"/>
</dbReference>
<dbReference type="PDB" id="2RAW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=1-142"/>
</dbReference>
<dbReference type="PDB" id="2RAX">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A/E/X=1-120"/>
</dbReference>
<dbReference type="PDB" id="3UEC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.18"/>
<property type="chains" value="A=1-142"/>
</dbReference>
<dbReference type="PDB" id="3UED">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/C=1-142"/>
</dbReference>
<dbReference type="PDB" id="3UEE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.61"/>
<property type="chains" value="A/C=1-142"/>
</dbReference>
<dbReference type="PDB" id="3UEF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="A/C=1-142"/>
</dbReference>
<dbReference type="PDB" id="3UEG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=1-142"/>
</dbReference>
<dbReference type="PDB" id="3UEH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=1-142"/>
</dbReference>
<dbReference type="PDB" id="3UEI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=1-142"/>
</dbReference>
<dbReference type="PDB" id="3UIG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=1-142"/>
</dbReference>
<dbReference type="PDB" id="3UIH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=1-142"/>
</dbReference>
<dbReference type="PDB" id="3UII">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=1-142"/>
</dbReference>
<dbReference type="PDB" id="3UIJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=1-142"/>
</dbReference>
<dbReference type="PDB" id="3UIK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=1-142"/>
</dbReference>
<dbReference type="PDB" id="4A0I">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=1-142"/>
</dbReference>
<dbReference type="PDB" id="4A0J">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=1-142"/>
</dbReference>
<dbReference type="PDB" id="4A0N">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.74"/>
<property type="chains" value="A=1-142"/>
</dbReference>
<dbReference type="PDB" id="6SHO">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/B=1-142"/>
</dbReference>
<dbReference type="PDB" id="6YIE">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.49"/>
<property type="chains" value="A/D=1-142"/>
</dbReference>
<dbReference type="PDB" id="6YIF">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.81"/>
<property type="chains" value="A=1-142"/>
</dbReference>
<dbReference type="PDB" id="6YIH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A=1-142"/>
</dbReference>
<dbReference type="PDBsum" id="1E31"/>
<dbReference type="PDBsum" id="1F3H"/>
<dbReference type="PDBsum" id="1XOX"/>
<dbReference type="PDBsum" id="2QFA"/>
<dbReference type="PDBsum" id="2RAW"/>
<dbReference type="PDBsum" id="2RAX"/>
<dbReference type="PDBsum" id="3UEC"/>
<dbReference type="PDBsum" id="3UED"/>
<dbReference type="PDBsum" id="3UEE"/>
<dbReference type="PDBsum" id="3UEF"/>
<dbReference type="PDBsum" id="3UEG"/>
<dbReference type="PDBsum" id="3UEH"/>
<dbReference type="PDBsum" id="3UEI"/>
<dbReference type="PDBsum" id="3UIG"/>
<dbReference type="PDBsum" id="3UIH"/>
<dbReference type="PDBsum" id="3UII"/>
<dbReference type="PDBsum" id="3UIJ"/>
<dbReference type="PDBsum" id="3UIK"/>
<dbReference type="PDBsum" id="4A0I"/>
<dbReference type="PDBsum" id="4A0J"/>
<dbReference type="PDBsum" id="4A0N"/>
<dbReference type="PDBsum" id="6SHO"/>
<dbReference type="PDBsum" id="6YIE"/>
<dbReference type="PDBsum" id="6YIF"/>
<dbReference type="PDBsum" id="6YIH"/>
<dbReference type="BMRB" id="O15392"/>
<dbReference type="SMR" id="O15392"/>
<dbReference type="BioGRID" id="106829">
<property type="interactions" value="76"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-111">
<property type="entry name" value="Survivin homodimer complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-116">
<property type="entry name" value="Chromosomal passenger complex"/>
</dbReference>
<dbReference type="CORUM" id="O15392"/>
<dbReference type="DIP" id="DIP-34662N"/>
<dbReference type="ELM" id="O15392"/>
<dbReference type="IntAct" id="O15392">
<property type="interactions" value="38"/>
</dbReference>
<dbReference type="MINT" id="O15392"/>
<dbReference type="BindingDB" id="O15392"/>
<dbReference type="ChEMBL" id="CHEMBL5989"/>
<dbReference type="DrugBank" id="DB04115">
<property type="generic name" value="Berberine"/>
</dbReference>
<dbReference type="DrugBank" id="DB05141">
<property type="generic name" value="LY2181308"/>
</dbReference>
<dbReference type="DrugBank" id="DB00206">
<property type="generic name" value="Reserpine"/>
</dbReference>
<dbReference type="DrugCentral" id="O15392"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2795"/>
<dbReference type="MEROPS" id="I32.005"/>
<dbReference type="iPTMnet" id="O15392"/>
<dbReference type="PhosphoSitePlus" id="O15392"/>
<dbReference type="BioMuta" id="BIRC5"/>
<dbReference type="EPD" id="O15392"/>
<dbReference type="jPOST" id="O15392"/>
<dbReference type="MassIVE" id="O15392"/>
<dbReference type="MaxQB" id="O15392"/>
<dbReference type="PeptideAtlas" id="O15392"/>
<dbReference type="PRIDE" id="O15392"/>
<dbReference type="ProteomicsDB" id="48627">
<molecule id="O15392-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="48628">
<molecule id="O15392-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="48629">
<molecule id="O15392-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="48630">
<molecule id="O15392-4"/>
</dbReference>
<dbReference type="ProteomicsDB" id="48631">
<molecule id="O15392-5"/>
</dbReference>
<dbReference type="ProteomicsDB" id="48632">
<molecule id="O15392-6"/>
</dbReference>
<dbReference type="ProteomicsDB" id="48633">
<molecule id="O15392-7"/>
</dbReference>
<dbReference type="ABCD" id="O15392">
<property type="antibodies" value="5 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="1073">
<property type="antibodies" value="1718 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="332"/>
<dbReference type="Ensembl" id="ENST00000374948">
<molecule id="O15392-3"/>
<property type="protein sequence ID" value="ENSP00000364086"/>
<property type="gene ID" value="ENSG00000089685"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000590449">
<molecule id="O15392-7"/>
<property type="protein sequence ID" value="ENSP00000465868"/>
<property type="gene ID" value="ENSG00000089685"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000590925">
<molecule id="O15392-4"/>
<property type="protein sequence ID" value="ENSP00000467336"/>
<property type="gene ID" value="ENSG00000089685"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000592734">
<molecule id="O15392-6"/>
<property type="protein sequence ID" value="ENSP00000466617"/>
<property type="gene ID" value="ENSG00000089685"/>
</dbReference>
<dbReference type="GeneID" id="332"/>
<dbReference type="KEGG" id="hsa:332"/>
<dbReference type="UCSC" id="uc002jvh.4">
<molecule id="O15392-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="332"/>
<dbReference type="DisGeNET" id="332"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000089685.14"/>
<dbReference type="GeneCards" id="BIRC5"/>
<dbReference type="HGNC" id="HGNC:593">
<property type="gene designation" value="BIRC5"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000089685">
<property type="expression patterns" value="Tissue enhanced (lymphoid tissue, testis)"/>
</dbReference>
<dbReference type="MIM" id="603352">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O15392"/>
<dbReference type="OpenTargets" id="ENSG00000089685"/>
<dbReference type="PharmGKB" id="PA25362"/>
<dbReference type="GeneTree" id="ENSGT00510000047537"/>
<dbReference type="HOGENOM" id="CLU_1869818_0_0_1"/>
<dbReference type="InParanoid" id="O15392"/>
<dbReference type="KO" id="K08731"/>
<dbReference type="OrthoDB" id="1404665at2759"/>
<dbReference type="PathwayCommons" id="O15392"/>
<dbReference type="Reactome" id="R-HSA-141444">
<property type="pathway name" value="Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2467813">
<property type="pathway name" value="Separation of Sister Chromatids"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2500257">
<property type="pathway name" value="Resolution of Sister Chromatid Cohesion"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4615885">
<property type="pathway name" value="SUMOylation of DNA replication proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5663220">
<property type="pathway name" value="RHO GTPases Activate Formins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785807">
<property type="pathway name" value="Interleukin-4 and Interleukin-13 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6803205">
<property type="pathway name" value="TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-68877">
<property type="pathway name" value="Mitotic Prometaphase"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8951664">
<property type="pathway name" value="Neddylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9648025">
<property type="pathway name" value="EML4 and NUDC in mitotic spindle formation"/>
</dbReference>
<dbReference type="SignaLink" id="O15392"/>
<dbReference type="SIGNOR" id="O15392"/>
<dbReference type="BioGRID-ORCS" id="332">
<property type="hits" value="762 hits in 875 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="BIRC5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="O15392"/>
<dbReference type="GeneWiki" id="Survivin"/>
<dbReference type="GenomeRNAi" id="332"/>
<dbReference type="Pharos" id="O15392">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:O15392"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 17"/>
</dbReference>
<dbReference type="RNAct" id="O15392">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000089685">
<property type="expression patterns" value="Expressed in ventricular zone and 153 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="O15392">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O15392">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005814">
<property type="term" value="C:centriole"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032133">
<property type="term" value="C:chromosome passenger complex"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000775">
<property type="term" value="C:chromosome, centromeric region"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000777">
<property type="term" value="C:condensed chromosome kinetochore"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005881">
<property type="term" value="C:cytoplasmic microtubule"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031021">
<property type="term" value="C:interphase microtubule organizing center"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030496">
<property type="term" value="C:midbody"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000228">
<property type="term" value="C:nuclear chromosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005876">
<property type="term" value="C:spindle microtubule"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051087">
<property type="term" value="F:chaperone binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050897">
<property type="term" value="F:cobalt ion binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043027">
<property type="term" value="F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0008017">
<property type="term" value="F:microtubule binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008536">
<property type="term" value="F:Ran GTPase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015631">
<property type="term" value="F:tubulin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051301">
<property type="term" value="P:cell division"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007059">
<property type="term" value="P:chromosome segregation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051303">
<property type="term" value="P:establishment of chromosome localization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000086">
<property type="term" value="P:G2/M transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000278">
<property type="term" value="P:mitotic cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000281">
<property type="term" value="P:mitotic cytokinesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090307">
<property type="term" value="P:mitotic spindle assembly"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007094">
<property type="term" value="P:mitotic spindle assembly checkpoint"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043154">
<property type="term" value="P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031536">
<property type="term" value="P:positive regulation of exit from mitosis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045931">
<property type="term" value="P:positive regulation of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031503">
<property type="term" value="P:protein-containing complex localization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042981">
<property type="term" value="P:regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007605">
<property type="term" value="P:sensory perception of sound"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd00022">
<property type="entry name" value="BIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00186"/>
<dbReference type="InterPro" id="IPR001370">
<property type="entry name" value="BIR_rpt"/>
</dbReference>
<dbReference type="Pfam" id="PF00653">
<property type="entry name" value="BIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00238">
<property type="entry name" value="BIR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50143">
<property type="entry name" value="BIR_REPEAT_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0132">Cell division</keyword>
<keyword id="KW-0137">Centromere</keyword>
<keyword id="KW-0158">Chromosome</keyword>
<keyword id="KW-0159">Chromosome partition</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0995">Kinetochore</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0493">Microtubule</keyword>
<keyword id="KW-0498">Mitosis</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0646">Protease inhibitor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0789">Thiol protease inhibitor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="chain" description="Baculoviral IAP repeat-containing protein 5" id="PRO_0000122356">
<location>
<begin position="1"/>
<end position="142"/>
</location>
</feature>
<feature type="repeat" description="BIR">
<location>
<begin position="18"/>
<end position="88"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="2 24">
<location>
<position position="57"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="2 24">
<location>
<position position="60"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="2 24">
<location>
<position position="77"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="2 24">
<location>
<position position="84"/>
</location>
</feature>
<feature type="site" description="Interaction with FBXL7" evidence="37">
<location>
<position position="126"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by AURKC" evidence="38">
<location>
<position position="20"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="29">
<location>
<position position="23"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CDK1 and CDK15" evidence="5 8 36">
<location>
<position position="34"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CK2; in vitro" evidence="32">
<location>
<position position="48"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="29">
<location>
<position position="90"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="29">
<location>
<position position="110"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="29">
<location>
<position position="112"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="29">
<location>
<position position="115"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by AURKB" evidence="11">
<location>
<position position="117"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="29">
<location>
<position position="121"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="29">
<location>
<position position="129"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_020338" evidence="41">
<original>IEEHKKHSSGCAFLSVKKQFEELTLGEFLKLDRERAKNKIAKETNNKKKEFEETAKKVRRAIEQLAAMD</original>
<variation>MQRKPTIRRKNLRKLRRKCAVPSSSWLPWIEASGRSCLVPEWLHHFQGLFPGATSLPVGPLAMS</variation>
<location>
<begin position="74"/>
<end position="142"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_020339" evidence="46">
<original>IEEHKKHSSGCAFLSVKKQFEELTLGEFLKLDRERAKNKIAKETNNKKKEFEETAKKVRRAIEQLAAMD</original>
<variation>MRELC</variation>
<location>
<begin position="74"/>
<end position="142"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 7." id="VSP_020340" evidence="45">
<original>IEEHKKHSSGCAFLSVKKQFEELTLGEFLKLDRERAKNKIAKETNNKKKEFEETAKKVRRAIEQLAAMD</original>
<variation>M</variation>
<location>
<begin position="74"/>
<end position="142"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_002454" evidence="41 44">
<original>I</original>
<variation>IGPGTVAYACNTSTLGGRGGRITR</variation>
<location>
<position position="74"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_020341" evidence="43">
<original>DRERAKNKIAKETNNKKKEFEETAKKVRRAIEQLAAMD</original>
<variation>VRETLPPPRSFIR</variation>
<location>
<begin position="105"/>
<end position="142"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_020342" evidence="42">
<original>AKETNNKKKEFEETAKKVRRAIEQLAAMD</original>
<variation>ERALLAE</variation>
<location>
<begin position="114"/>
<end position="142"/>
</location>
</feature>
<feature type="sequence variant" description="Loss of acetylation; localization primarily within the cytoplasm; increased likelihood of existing as monomer; stronger binding to XPO1/CRM1; dbSNP:rs2071214." id="VAR_021071" evidence="21 29">
<original>K</original>
<variation>E</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts interaction with histone H3pT3, no effect on interaction with INCENP." evidence="30">
<original>R</original>
<variation>A</variation>
<location>
<position position="18"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases ubiquitination and blocks dissociation from centromeres; when associated with R-62; R-78 and R-79." evidence="17">
<original>K</original>
<variation>R</variation>
<location>
<position position="23"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts interaction with histone H3pT3, no effect on interaction with INCENP." evidence="30">
<original>W</original>
<variation>A</variation>
<location>
<position position="25"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts interaction with histone H3pT3, no effect on interaction with INCENP." evidence="30">
<original>C</original>
<variation>R</variation>
<location>
<position position="33"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of LAMTOR5 binding." evidence="10">
<original>T</original>
<variation>A</variation>
<location>
<position position="34"/>
</location>
</feature>
<feature type="mutagenesis site" description="Higher affinity for LAMTOR5 binding." evidence="10">
<original>T</original>
<variation>E</variation>
<location>
<position position="34"/>
</location>
</feature>
<feature type="mutagenesis site" description="Localizes normally during mitosis but cannot support cell proliferation. Increased affinity for CDCA8/borealin." evidence="32">
<original>T</original>
<variation>A</variation>
<variation>E</variation>
<location>
<position position="48"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts interaction with histone H3pT3, no effect on interaction with INCENP." evidence="30">
<original>C</original>
<variation>A</variation>
<location>
<position position="57"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases ubiquitination and blocks dissociation from centromeres; when associated with R-23; R-78 and R-79." evidence="17">
<original>K</original>
<variation>R</variation>
<location>
<position position="62"/>
</location>
</feature>
<feature type="mutagenesis site" description="Almost abolishes RAN-binding. Does not disrupt binding to AURKB or CDCA8. Disrupts mitotic spindle assembly. Does not disrupt nuclear export." evidence="27">
<original>E</original>
<variation>A</variation>
<location>
<position position="65"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts interaction with histone H3pT3, no effect on interaction with INCENP." evidence="30">
<original>W</original>
<variation>A</variation>
<location>
<position position="67"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change. Loss of interaction with AURKB; when associated with A-71." evidence="22">
<original>D</original>
<variation>A</variation>
<location>
<position position="70"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change. Loss of interaction with AURKB; when associated with A-70." evidence="22">
<original>D</original>
<variation>A</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases ubiquitination and blocks dissociation from centromeres; when associated with R-23; R-62 and R-79." evidence="17">
<original>K</original>
<variation>R</variation>
<location>
<position position="78"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases ubiquitination and blocks dissociation from centromeres; when associated with R-23; R-62 and R-78." evidence="17">
<original>K</original>
<variation>R</variation>
<location>
<position position="79"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of cytoprotection.">
<original>C</original>
<variation>A</variation>
<location>
<position position="84"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of FBXL7 mediated polyubiquitination." evidence="37">
<original>KK</original>
<variation>RR</variation>
<location>
<begin position="90"/>
<end position="91"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents phosphorylation by AURKB. Still able to localize correctly but prevents interaction with INCENP." evidence="11">
<original>T</original>
<variation>A</variation>
<location>
<position position="117"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mimics phosphorylation. Disrupts subcellular localization during mitosis and prevents interaction with INCENP." evidence="11">
<original>T</original>
<variation>E</variation>
<location>
<position position="117"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of FBXL7 binding." evidence="37">
<original>E</original>
<variation>A</variation>
<location>
<position position="126"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mimics acetylation. Localization primarily within the nucleus." evidence="29">
<original>K</original>
<variation>A</variation>
<variation>Q</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of acetylation. Localization primarily within the cytoplasm." evidence="29">
<original>K</original>
<variation>R</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAW22624." ref="5" evidence="47">
<original>CF</original>
<variation>WV</variation>
<location>
<begin position="57"/>
<end position="58"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 11; BAD97148." ref="11" evidence="47">
<original>F</original>
<variation>L</variation>
<location>
<position position="58"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 9; CAG46540." ref="9" evidence="47">
<original>A</original>
<variation>V</variation>
<location>
<position position="128"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="8"/>
<end position="10"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="11"/>
<end position="13"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="15"/>
<end position="20"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="29"/>
<end position="32"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="35"/>
<end position="40"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="43"/>
<end position="45"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="49"/>
<end position="51"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="55"/>
<end position="57"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="58"/>
<end position="60"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="63"/>
<end position="65"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="73"/>
<end position="80"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="81"/>
<end position="83"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="85"/>
<end position="88"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="93"/>
<end position="95"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="98"/>
<end position="139"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1F3H"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2QFA"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3UIG"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6YIF"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="E3SCZ8"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10626797"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11069302"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11084331"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12773388"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14610074"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14741722"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15249581"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15665297"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16239925"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16291752"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16322459"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16329164"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16427043"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16436504"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16625196"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16762323"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16764853"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17956729"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17993464"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18329369"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18591255"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20627126"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20826784"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20929775"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21225229"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21252625"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21364656"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21536684"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24793696"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24866247"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25778398"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27332895"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28218735"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9859993"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10626797"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14741722"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="16329164"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000303">
<source ref="6"/>
</evidence>
<evidence key="45" type="ECO:0000303">
<source ref="7"/>
</evidence>
<evidence key="46" type="ECO:0000303">
<source ref="8"/>
</evidence>
<evidence key="47" type="ECO:0000305"/>
<sequence length="142" mass="16389" checksum="9E7CADCDF2822286" modified="2012-03-21" version="3">MGAPTLPPAWQPFLKDHRISTFKNWPFLEGCACTPERMAEAGFIHCPTENEPDLAQCFFCFKELEGWEPDDDPIEEHKKHSSGCAFLSVKKQFEELTLGEFLKLDRERAKNKIAKETNNKKKEFEETAKKVRRAIEQLAAMD</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

